SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia

by Puissant, Alexandre, Alexe, Gabriela, Pikman, Yana, Bassil, Christopher F, Mehta, Swapnil, Du, Jinyan, Kazi, Julhash U, Luciano, Frédéric, Rönnstrand, Lars, Kung, Andrew L, Aster, Jon C, Galinsky, Ilene, Stone, Richard M, DeAngelo, Daniel J, Stegmaier, Kimberly, Fenouille, Nina, Hemann, Michael
Published 2017

The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia

by Bassil, Christopher F, Ben-Sahra, Issam, Benajiba, Lina, Alexe, Gabriela, Pikman, Yana, Conway, Amy S, Burgess, Michael R, Li, Qing, Luciano, Frédéric, Auberger, Patrick, Galinsky, Ilene, DeAngelo, Daniel J, Stone, Richard M, Zhang, Yi, Perkins, Archibald S, Shannon, Kevin, Puissant, Alexandre, Stegmaier, Kimberly, Fenouille, Nina, Ramos, Azucena, Hemann, Michael
Published 2018

Targeting MTHFD2 in acute myeloid leukemia

by Pikman, Yana, Alexe, Gabriela, Furman, Andrew, Chen, Liying M., Frumm, Stacey M., Ross, Linda, Fenouille, Nina, Bassil, Christopher F., Gould, Joshua, Stone, Richard M., DeAngelo, Daniel J., Galinsky, Ilene, Clish, Clary B., Kung, Andrew L., Banerji, Versha, Stegmaier, Kimberly, Puissant, Alexandre, Lewis, Caroline, Ramos, Azucena, Hemann, Michael, Vander Heiden, Matthew G.
Published 2017

Targeting MTHFD2 in acute myeloid leukemia

by Pikman, Yana, Puissant, Alexandre, Alexe, Gabriela, Furman, Andrew, Chen, Liying M., Frumm, Stacey M., Ross, Linda, Fenouille, Nina, Bassil, Christopher F., Lewis, Caroline, Ramos, Azucena, Gould, Joshua, Stone, Richard M., DeAngelo, Daniel J., Galinsky, Ilene, Clish, Clary B., Kung, Andrew L., Hemann, Michael, Vander Heiden, Matthew G., Banerji, Versha, Stegmaier, Kimberly
Published 2022